pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

18,423 catalysts · 4,728 grant · 3,415 8k filing · 2,627 approval · 2,156 device 510k · 1,745 device recall · 1,501 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 0 catalysts2026-08-18: 0 catalysts2026-08-19: 14 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-08-08×clear all
type
  • grant4,728
  • 8k filing3,415
  • approval2,627
  • device 510k2,156
  • device recall1,745
  • device pma1,501
device adverse event
1,000
  • recall586
  • earnings584
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Sep 22, 2025

    50
    ›Sep 22, 2025grant332d agoKAMUZU UNIVERSITY OF HEALTH SCIENCES — DIRECT: Enhancing Bioethics Capacities at Kamuzu University of Health Science...

    TW grant. $278,212. PI: Kazione Kulisewa

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoTURING MEDICAL TECHNOLOGIES INC — Real-time head motion monitoring for all clinical MR sequences using Universa...

    AG grant. $699,964. PI: Kevin King

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoWEILL MEDICAL COLL OF CORNELL UNIV — Lysosome homeostasis in aging-related diseases

    AG grant. $51,038. PI: Alison Drake Klein

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoUnknown institution — Small Molecules and Biologics Toxicology Consultant Support ServicesVincere Biosciences Inc

    DA grant. $8,800

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoMIDWEST RESEARCH INSTITUTE — MANUFACTURE OF CLINICAL GRADE EPSTEIN-BARR VIRUS VACCINE

    CA grant. $3,460,074

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoHENRY M. JACKSON FDN FOR THE ADV MIL/MED — Mechanisms of Radiation-induced Hemolysis

    ES grant. $340,383. PI: Regina M Day

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoWEILL MEDICAL COLL OF CORNELL UNIV — Mechanism and rescue of lysosomal defects in Adult-onset Neuronal Ceroid Lipo...

    NS grant. $49,538. PI: Samantha R McDonough

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoUNIVERSITY OF CALIFORNIA BERKELEY — Reactivating regulatory programs for regeneration

    HL grant. $112,350. PI: Megan Lee Martik

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON — EMED: An Ethical Mixture-of-Experts Digital Twin Framework for Medical Device...

    OD grant. $1,999,996. PI: Hanjie Chen

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoCARROLL UNIVERSITY — Influence of a supervised postpartum exercise program on maternal physical ac...

    HD grant. $343,320. PI: RITA DEERING

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoOHIO STATE UNIVERSITY — Insulin-accelerated surgical approach to pre-retinal gene therapyShanghai Jiao Tong University

    EY grant. $206,739. PI: THOMAS ALLAN MENDEL

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoNUVOX PHARMA, LLC — Liquid Biopsy in Glioblastoma Treated with Chemoradiation and an Oxygen Thera...NuvOx Pharma LLC

    CA grant. $919,366. PI: Katherine Havranek

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoEMORY UNIVERSITY — A Phase 2b randomized open label trial to assess the quality and balance of d...Emory University

    AI grant. $299,430. PI: Matthew Collins

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoUNIVERSITY OF MINNESOTA — In vivo hematopoietic stem cell gene therapy in a novel genetically humanized...University of Minnesota

    AI grant. $36,093. PI: Ella Joy Eaton

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoCINCINNATI CHILDRENS HOSP MED CTR — Contributions of de novo lipid synthesis to hematopoietic stem cell function

    HL grant. $42,479. PI: Sydney Treichel

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoCOLUMBIA UNIV NEW YORK MORNINGSIDE — Quantifying Relationships Between Behavior, Neural Network and Metabolic Dysf...

    NS grant. $49,538. PI: Kaitlyn Swayze

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Co-Designing and Evaluating Additional Mothers and Babies Program Content for...Northwestern University

    MH grant. $720,000. PI: HEATHER Jill RISSER

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoWESTERN UNIVERSITY OF HEALTH SCIENCES — Training Interprofessional Community-Engaged Research Teams (TICERT)

    NR grant. $216,731. PI: Mary Lopez

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoCHILDREN'S MERCY HOSP (KANSAS CITY, MO) — Feasibility Trial of Home-Based Immersive Neurofeedback Self-Regulation Train...

    AT grant. $753,142. PI: Mark Andrew Connelly

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoUNIVERSITY OF TENNESSEE KNOXVILLE — Supporting FDA's Integrated Food Safety System Training Delivery and Development

    FD grant. $500,000. PI: Sharon R Thompson

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoGLOBAL FOOD PROTECTION INSTITUTE D/B/A INTERNATIONAL FOOD PROTECTION TRAINING INSTITUTE — Supporting the Advancement of FDA's Integrated Food Safety System (IFSS) Trai...

    FD grant. $500,000. PI: Craig Kaml

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoTOXSTRATEGIES, INC. — Small Molecules and Biologics Toxicology Consultant Support ServicesVincere Biosciences Inc

    DA grant. $28,000

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoJACKSON LABORATORY — REPOSITORY OF MOUSE MODELS FOR DOWN SYNDROME

    HD grant. $649,999. PI: CATHLEEN LUTZ

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoJOHNS HOPKINS UNIVERSITY — Galvanic vestibular stimulation: from cellular mechanisms to behavioral respo...Johns Hopkins University

    DC grant. $226,958. PI: Gene Yevgeny Fridman

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoMERLIN BIOTECH INC — SBIR FY25 Concept Award, Development of an Immunotherapy for Ewing Sarcoma Us...MERLIN Biotech LLC

    CA grant. $355,000

    full page →nih reporter ↗
    ›Sep 22, 2025grant332d agoUnknown institution — SUBJECT MATTER EXPERT FOR PROCESS CHEMISTRY DEVELOPMENT

    DA grant. $8,460

    full page →nih reporter ↗
    ›Sep 23, 2025approval331d agoCONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Sep 23, 2025approval331d agoQUILLICHEW ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: NEXTWAVE PHARMS. Form: TABLET, EXTENDED RELEASE, CHEWABLE. Route: ORAL

    full page →fda approvals ↗
    ›Sep 23, 2025approval331d agoQUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: NEXTWAVE. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Sep 23, 2025approval331d agoCAMCEVI KIT (LEUPROLIDE MESYLATE) — FDA approvalForesee Pharmaceuticals Co Ltd

    Sponsor: ACCORD. Form: EMULSION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Sep 23, 2025approval331d agoCAPRELSA (VANDETANIB) — FDA approvalvandetanib

    Sponsor: GENZYME CORP. Form: TABLET. Route: ORAL

    full page →vandetanib →fda approvals ↗
    ›Sep 23, 2025approval331d agoLUPRON DEPOT-PED KIT (LEUPROLIDE ACETATE) — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: ABBVIE ENDOCRINE INC. Form: POWDER. Route: INTRAMUSCULAR

    full page →fda approvals ↗
    ›Sep 23, 2025approval331d agoLUPRON (LEUPROLIDE ACETATE) — FDA approvalInvaGen Pharmaceuticals Inc

    Sponsor: ABBVIE ENDOCRINE INC. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Sep 23, 2025approval331d agoFLAREX (FLUOROMETHOLONE ACETATE) — FDA approvalHARROW, INC.

    Sponsor: HARROW EYE. Form: SUSPENSION/DROPS. Route: OPHTHALMIC

    full page →fda approvals ↗
    ›Sep 23, 2025approval331d agoALVIMOPAN — FDA approvalALVIMOPAN

    Sponsor: HIKMA. Form: CAPSULE. Route: ORAL

    full page →ALVIMOPAN →fda approvals ↗
    ›Sep 23, 2025approval331d agoJORNAY PM (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: IRONSHORE PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Sep 23, 2025approval331d agoCIMZIA (CERTOLIZUMAB PEGOL) — FDA approvalcertolizumab pegol

    Sponsor: UCB INC. Form: INJECTABLE. Route: INJECTION

    full page →certolizumab pegol →fda approvals ↗
    ›Sep 23, 2025approval331d agoTRIPTODUR KIT (TRIPTORELIN PAMOATE) — FDA approvaltriptorelin pamoate ER

    Sponsor: AZURITY. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR

    full page →triptorelin pamoate ER →fda approvals ↗
    ›Sep 23, 2025approval331d agoDEXEDRINE SPANSULE (DEXTROAMPHETAMINE SULFATE) — FDA approvalMallinckrodt LLC

    Sponsor: IMPAX LABS INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Sep 23, 2025approval331d agoFOCALIN XR (DEXMETHYLPHENIDATE HYDROCHLORIDE) — FDA approvaldexmethylphenidate hydrochloride ER

    Sponsor: SANDOZ. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →dexmethylphenidate hydrochloride ER →fda approvals ↗
    ›Sep 23, 2025approval331d agoFENSOLVI KIT (LEUPROLIDE ACETATE) — FDA approvalLEUPROLIDE ACETATE

    Sponsor: TOLMAR. Form: POWDER. Route: SUBCUTANEOUS

    full page →LEUPROLIDE ACETATE →fda approvals ↗
    ›Sep 23, 2025approval331d agoTRELSTAR (TRIPTORELIN PAMOATE) — FDA approvaltriptorelin pamoate ER

    Sponsor: VERITY. Form: INJECTABLE. Route: INTRAMUSCULAR

    full page →triptorelin pamoate ER →fda approvals ↗
    ›Sep 23, 2025approval331d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalMETHYLPHENIDATE HYDROCHLORIDE

    Sponsor: ABHAI LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METHYLPHENIDATE HYDROCHLORIDE →fda approvals ↗
    ›Sep 23, 2025approval331d agoLEUPROLIDE ACETATE — FDA approvalInvaGen Pharmaceuticals Inc

    Sponsor: SUN PHARM. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Sep 23, 2025approval331d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalMETHYLPHENIDATE HYDROCHLORIDE

    Sponsor: ALVOGEN. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METHYLPHENIDATE HYDROCHLORIDE →fda approvals ↗
    ›Sep 23, 2025approval331d agoRELEXXII (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: OSMOTICA PHARM US. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Sep 23, 2025approval331d agoALVIMOPAN — FDA approvalPar Pharmaceutical Inc

    Sponsor: WATSON LABS TEVA. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Sep 23, 2025approval331d agoZOLADEX (GOSERELIN ACETATE) — FDA approvalgoserelin LA

    Sponsor: TERSERA. Form: IMPLANT. Route: IMPLANTATION

    full page →goserelin LA →fda approvals ↗
    ›Sep 23, 2025approval331d agoPRIMIDONE — FDA approvalFrontida Biopharm Inc

    Sponsor: WATSON LABS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 23, 2025approval331d agoDAYTRANA (METHYLPHENIDATE) — FDA approvalNoven Pharmaceuticals Inc

    Sponsor: NOVEN PHARMS INC. Form: FILM, EXTENDED RELEASE. Route: TRANSDERMAL

    full page →fda approvals ↗
    ← prev
    page 60 of 369
    next →
    $COLL29.28+2.74%
    $COLL29.28+2.74%
    $HROW41.81+5.79%
    $COLL29.28+2.74%
    $AMRX18.06-0.71%
    $COLL29.28+2.74%